NDC 63304-652

Acyclovir

Acyclovir

Acyclovir is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Ranbaxy Laboratories Ltd.. The primary component is Acyclovir.

Product ID63304-652_7a18c7e7-b635-439a-8f8b-8dac5704fba6
NDC63304-652
Product TypeHuman Prescription Drug
Proprietary NameAcyclovir
Generic NameAcyclovir
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1999-02-08
Marketing CategoryANDA / ANDA
Application NumberANDA074975
Labeler NameRanbaxy Laboratories Ltd.
Substance NameACYCLOVIR
Active Ingredient Strength200 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 63304-652-10

1000 CAPSULE in 1 BOTTLE (63304-652-10)
Marketing Start Date1999-02-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63304-652-05 [63304065205]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA074975
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-02-08
Inactivation Date2020-01-31

NDC 63304-652-10 [63304065210]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA074975
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-06-29
Inactivation Date2020-01-31

NDC 63304-652-50 [63304065250]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA074975
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-01-20
Inactivation Date2020-01-31

NDC 63304-652-01 [63304065201]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA074975
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-02-08
Inactivation Date2020-01-31

NDC 63304-652-20 [63304065220]

Acyclovir CAPSULE
Marketing CategoryANDA
Application NumberANDA074975
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-06-29
Marketing End Date2012-01-20

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR200 mg/1

OpenFDA Data

SPL SET ID:d13b8cdd-59fd-472b-8125-a19f42ef5402
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197311
  • 197310
  • 197313
    • UPC Code
  • 0363304505016

    • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    Medicade Reported Pricing

    63304065201 ACYCLOVIR 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Acyclovir" or generic name "Acyclovir"

    NDCBrand NameGeneric Name
    0093-3630Acycloviracyclovir
    0093-8940AcyclovirAcyclovir
    0093-8943AcyclovirAcyclovir
    0093-8947AcyclovirAcyclovir
    0143-9657AcyclovirAcyclovir
    0143-9658AcyclovirAcyclovir
    0168-0825acycloviracyclovir
    0378-8700Acycloviracyclovir
    0378-8712AcyclovirAcyclovir
    0440-6030AcyclovirAcyclovir
    0440-7033acycloviracyclovir
    0472-0082AcyclovirAcyclovir
    0591-1159Acycloviracyclovir
    0713-0630AcyclovirAcyclovir
    0904-5789ACYCLOVIRACYCLOVIR
    0904-5790acycloviracyclovir
    10544-039Acycloviracyclovir
    10544-089Acycloviracyclovir
    10544-101AcyclovirAcyclovir
    68071-1841AcyclovirAcyclovir
    68071-3155AcyclovirAcyclovir
    68071-3222AcyclovirAcyclovir
    68071-4528AcyclovirAcyclovir
    68071-4559acycloviracyclovir
    68071-4345AcyclovirAcyclovir
    68084-109AcyclovirAcyclovir
    68084-108AcyclovirAcyclovir
    68071-4790AcyclovirAcyclovir
    68071-4799AcyclovirAcyclovir
    68084-107ACYCLOVIRACYCLOVIR
    68382-125acycloviracyclovir
    68382-049acycloviracyclovir
    68382-048acycloviracyclovir
    68382-668acycloviracyclovir
    68382-126acycloviracyclovir
    68382-792acycloviracyclovir
    68382-791acycloviracyclovir
    68382-992acycloviracyclovir
    68462-746acycloviracyclovir
    68788-6360acycloviracyclovir
    68788-0505AcyclovirAcyclovir
    68788-0504AcyclovirAcyclovir
    68788-0715AcyclovirAcyclovir
    68788-8989acycloviracyclovir
    68788-6827ACYCLOVIRACYCLOVIR
    68788-7382acycloviracyclovir
    68788-7378acycloviracyclovir
    68788-9783AcyclovirAcyclovir
    68788-7342AcyclovirAcyclovir
    68788-9690AcyclovirAcyclovir
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.